A trial looking at a vaccine to prevent shingles in people with blood cancers

Overview

Blood cancers, Cell type, Leukaemia, Lymphoma, Myeloma

Results

Phase 3

This trial looked at a vaccine called HZ/su to prevent shingles in people who are having or have had treatment for blood cancers.

Blood cancers include:

This trial was open for people to join between 2013 and 2015. The results were presented at a conference in 2018.

Recruitment start: 4 April 2013

Recruitment end: 11 September 2015

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Dr Andy Peniket

GlaxoSmithKline (GSK)

NIHR Clinical Research Network: Cancer

Last reviewed: 20 Feb 2020

CRUK internal database number: 10959

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

What to ask your doctor about clinical trials.

Meet and chat to other cancer people affected by cancer.

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.